In addition, recent reports reveal the potential applicationofBasidiomycota metabolites in neurodegenerative disease (NDD) treatmentowing to their nerve growth factor (NGF)-potentiating and/or NGF-mimickingeffects.7 NDDs result in progressive malfunctionof the nervous system and affect millions globally, with more than$600 billion incurred in their management.7 The gene discussed is NGF; the disease is neurodegenerative disease.